Early Detection of Renal Impairment Among Patients with Type 2 Diabetes Mellitus Through Evaluation of Serum Cystatin C in Comparison with Serum Creatinine Levels: A Cross-Sectional Study

Tadesse Asmamaw,1 Solomon Genet,2 Menakath Menon,2 Getahun Tarekegn,3 Endeshaw Chekol,4 Zeleke Geto,5 Tadesse Lejisa,5 Wossene Habtu,5 Tigist Getahun,5 Yosef Tolcha5 1Department of Biochemistry, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia; 2Dep...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Asmamaw T, Genet S, Menon M, Tarekegn G, Chekol E, Geto Z, Lejisa T, Habtu W, Getahun T, Tolcha Y
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	diabetic nephropathy type 2 diabetes serum cystatin c creatinine Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/f354e3bdbcf34a3abc0c9dfa48cae2da
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f354e3bdbcf34a3abc0c9dfa48cae2da
record_format	dspace
spelling	oai:doaj.org-article:f354e3bdbcf34a3abc0c9dfa48cae2da2021-12-02T15:16:29ZEarly Detection of Renal Impairment Among Patients with Type 2 Diabetes Mellitus Through Evaluation of Serum Cystatin C in Comparison with Serum Creatinine Levels: A Cross-Sectional Study1178-7007https://doaj.org/article/f354e3bdbcf34a3abc0c9dfa48cae2da2020-12-01T00:00:00Zhttps://www.dovepress.com/early-detection-of-renal-impairment-among-patients-with-type-2-diabete-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Tadesse Asmamaw,1 Solomon Genet,2 Menakath Menon,2 Getahun Tarekegn,3 Endeshaw Chekol,4 Zeleke Geto,5 Tadesse Lejisa,5 Wossene Habtu,5 Tigist Getahun,5 Yosef Tolcha5 1Department of Biochemistry, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia; 2Department of Biochemistry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia; 3Department of Internal Medicine, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia; 4Department of Biochemistry, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia; 5National Reference Laboratory for Clinical Chemistry, Ethiopian Public Health Institute, Addis Ababa, EthiopiaCorrespondence: Tadesse Asmamaw Email as24tadesse@gmail.comBackground: The proportion of patients with end-stage renal disease caused by diabetes has progressively increased during the last few decades. Serum creatinine level is the most commonly used biochemical parameter to estimate GFR in routine practice. However, 50% of GFR can be lost before significant elevation of serum creatinine. Cystatin C is found to be a new promising marker for early detection of renal diseases.Objective of the Study: The aim of this study was to determine the value of serum cystatin C and serum creatinine levels for early detection of renal disease in patients with type 2 diabetes mellitus.Methodology: A hospital-based comparative cross-sectional study was conducted with a sample size of 120. For early detection of renal disease in patients with type 2 diabetes mellitus, serum creatinine and cystatin C levels were measured and compared.Result and Discussion: Serum creatinine and cystatin C levels were significantly increased in patients with type 2 diabetes mellitus compared to healthy controls. The mean±SD value of serum creatinine was found to be 0.87± 0.44 mg/dL in patients and 0.63± 0.27 mg/dL in control. Serum cystatin C level was also found to be significantly (P=0.0001) higher in patients (0.92± 0.38 mg/L) compared to controls (0.52± 0.20 mg/L). The mean±SD of eGFR in three equations (Creatinine Equation, Cystatin C Equation, and Creatinine–Cystatin C Equation) were 105.7± 27.5 mL/min/m2, 90.4± 28.2 mL/min/m2, and 100± 29.5 mL/min/m2, respectively.Conclusion: Cystatin C-based GFR estimation equations detect renal impairment in patients with type 2 diabetes mellitus earlier than creatinine-based GFR estimation equations.Keywords: diabetic nephropathy, type 2 diabetes, serum cystatin C, creatinineAsmamaw TGenet SMenon MTarekegn GChekol EGeto ZLejisa THabtu WGetahun TTolcha YDove Medical Pressarticlediabetic nephropathytype 2 diabetesserum cystatin ccreatinineSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 13, Pp 4727-4735 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	diabetic nephropathy type 2 diabetes serum cystatin c creatinine Specialties of internal medicine RC581-951
spellingShingle	diabetic nephropathy type 2 diabetes serum cystatin c creatinine Specialties of internal medicine RC581-951 Asmamaw T Genet S Menon M Tarekegn G Chekol E Geto Z Lejisa T Habtu W Getahun T Tolcha Y Early Detection of Renal Impairment Among Patients with Type 2 Diabetes Mellitus Through Evaluation of Serum Cystatin C in Comparison with Serum Creatinine Levels: A Cross-Sectional Study
description	Tadesse Asmamaw,1 Solomon Genet,2 Menakath Menon,2 Getahun Tarekegn,3 Endeshaw Chekol,4 Zeleke Geto,5 Tadesse Lejisa,5 Wossene Habtu,5 Tigist Getahun,5 Yosef Tolcha5 1Department of Biochemistry, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia; 2Department of Biochemistry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia; 3Department of Internal Medicine, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia; 4Department of Biochemistry, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia; 5National Reference Laboratory for Clinical Chemistry, Ethiopian Public Health Institute, Addis Ababa, EthiopiaCorrespondence: Tadesse Asmamaw Email as24tadesse@gmail.comBackground: The proportion of patients with end-stage renal disease caused by diabetes has progressively increased during the last few decades. Serum creatinine level is the most commonly used biochemical parameter to estimate GFR in routine practice. However, 50% of GFR can be lost before significant elevation of serum creatinine. Cystatin C is found to be a new promising marker for early detection of renal diseases.Objective of the Study: The aim of this study was to determine the value of serum cystatin C and serum creatinine levels for early detection of renal disease in patients with type 2 diabetes mellitus.Methodology: A hospital-based comparative cross-sectional study was conducted with a sample size of 120. For early detection of renal disease in patients with type 2 diabetes mellitus, serum creatinine and cystatin C levels were measured and compared.Result and Discussion: Serum creatinine and cystatin C levels were significantly increased in patients with type 2 diabetes mellitus compared to healthy controls. The mean±SD value of serum creatinine was found to be 0.87± 0.44 mg/dL in patients and 0.63± 0.27 mg/dL in control. Serum cystatin C level was also found to be significantly (P=0.0001) higher in patients (0.92± 0.38 mg/L) compared to controls (0.52± 0.20 mg/L). The mean±SD of eGFR in three equations (Creatinine Equation, Cystatin C Equation, and Creatinine–Cystatin C Equation) were 105.7± 27.5 mL/min/m2, 90.4± 28.2 mL/min/m2, and 100± 29.5 mL/min/m2, respectively.Conclusion: Cystatin C-based GFR estimation equations detect renal impairment in patients with type 2 diabetes mellitus earlier than creatinine-based GFR estimation equations.Keywords: diabetic nephropathy, type 2 diabetes, serum cystatin C, creatinine
format	article
author	Asmamaw T Genet S Menon M Tarekegn G Chekol E Geto Z Lejisa T Habtu W Getahun T Tolcha Y
author_facet	Asmamaw T Genet S Menon M Tarekegn G Chekol E Geto Z Lejisa T Habtu W Getahun T Tolcha Y
author_sort	Asmamaw T
title	Early Detection of Renal Impairment Among Patients with Type 2 Diabetes Mellitus Through Evaluation of Serum Cystatin C in Comparison with Serum Creatinine Levels: A Cross-Sectional Study
title_short	Early Detection of Renal Impairment Among Patients with Type 2 Diabetes Mellitus Through Evaluation of Serum Cystatin C in Comparison with Serum Creatinine Levels: A Cross-Sectional Study
title_full	Early Detection of Renal Impairment Among Patients with Type 2 Diabetes Mellitus Through Evaluation of Serum Cystatin C in Comparison with Serum Creatinine Levels: A Cross-Sectional Study
title_fullStr	Early Detection of Renal Impairment Among Patients with Type 2 Diabetes Mellitus Through Evaluation of Serum Cystatin C in Comparison with Serum Creatinine Levels: A Cross-Sectional Study
title_full_unstemmed	Early Detection of Renal Impairment Among Patients with Type 2 Diabetes Mellitus Through Evaluation of Serum Cystatin C in Comparison with Serum Creatinine Levels: A Cross-Sectional Study
title_sort	early detection of renal impairment among patients with type 2 diabetes mellitus through evaluation of serum cystatin c in comparison with serum creatinine levels: a cross-sectional study
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/f354e3bdbcf34a3abc0c9dfa48cae2da
work_keys_str_mv	AT asmamawt earlydetectionofrenalimpairmentamongpatientswithtype2diabetesmellitusthroughevaluationofserumcystatincincomparisonwithserumcreatininelevelsacrosssectionalstudy AT genets earlydetectionofrenalimpairmentamongpatientswithtype2diabetesmellitusthroughevaluationofserumcystatincincomparisonwithserumcreatininelevelsacrosssectionalstudy AT menonm earlydetectionofrenalimpairmentamongpatientswithtype2diabetesmellitusthroughevaluationofserumcystatincincomparisonwithserumcreatininelevelsacrosssectionalstudy AT tarekegng earlydetectionofrenalimpairmentamongpatientswithtype2diabetesmellitusthroughevaluationofserumcystatincincomparisonwithserumcreatininelevelsacrosssectionalstudy AT chekole earlydetectionofrenalimpairmentamongpatientswithtype2diabetesmellitusthroughevaluationofserumcystatincincomparisonwithserumcreatininelevelsacrosssectionalstudy AT getoz earlydetectionofrenalimpairmentamongpatientswithtype2diabetesmellitusthroughevaluationofserumcystatincincomparisonwithserumcreatininelevelsacrosssectionalstudy AT lejisat earlydetectionofrenalimpairmentamongpatientswithtype2diabetesmellitusthroughevaluationofserumcystatincincomparisonwithserumcreatininelevelsacrosssectionalstudy AT habtuw earlydetectionofrenalimpairmentamongpatientswithtype2diabetesmellitusthroughevaluationofserumcystatincincomparisonwithserumcreatininelevelsacrosssectionalstudy AT getahunt earlydetectionofrenalimpairmentamongpatientswithtype2diabetesmellitusthroughevaluationofserumcystatincincomparisonwithserumcreatininelevelsacrosssectionalstudy AT tolchay earlydetectionofrenalimpairmentamongpatientswithtype2diabetesmellitusthroughevaluationofserumcystatincincomparisonwithserumcreatininelevelsacrosssectionalstudy
_version_	1718387484222554112

Early Detection of Renal Impairment Among Patients with Type 2 Diabetes Mellitus Through Evaluation of Serum Cystatin C in Comparison with Serum Creatinine Levels: A Cross-Sectional Study

Ejemplares similares